Use of the Perclose ProGlide suture-mediated closure strategy to achieve vascular access-site hemostasis after transfemoral TAVR results in fewer major vascular complications than does deployment of ...

Results from an analysis of a large randomized trial shows ProGlide vascular closure device (VCD) was associated with lower rates of vascular complications, lower rates of acute kidney injury (AKI) ...

The plug-based Manta (Teleflex) device was associated with significantly more vascular complications than the suture-based ProGlide (Abbott Vascular) device following transfemoral transcatheter aortic ...

For large-bore arterial access site closure after transfemoral transcatheter aortic valve replacement (TAVR), use of the Manta plug-based vascular closure device resulted in significantly more ...

BioWorld - Tuesday, July 30, 2024 See today's BioWorld MedTech Home » Merged firms seek lock down of percutaneous wound market with suture holding device Subscribe to BioWorld™ news services See ...

HOLLYWOOD, FL—Several large-bore closure devices seem poised to soon enter the US interventionalist’s toolbox, with “explosive growth” expected in their use given the rise in transcatheter aortic ...

LAS VEGAS (MAY 21, 2019) - Results from an analysis of a large randomized trial shows ProGlide vascular closure device (VCD) was associated with lower rates of vascular complications, lower rates of ...

Ra Medical Systems Inc. launched a simple device that holds sutures more securely in place for closure of percutaneous wound sites during cardiac electrophysiology, structural heart and vascular ...